| MolName | 3-[(5Z)-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid |
| MolecularFormula | C23H20N4O5S2 |
| Smiles | OC(CNC(N=C1N2C=CC=C1)=C(/C=C(/C(N1CCC(O)=O)=O)\SC1=S)C2=O)c1ccccc1 |
| InChI | InChI=1S/C23H20N4O5S2/c28-16(14-6-2-1-3-7-14)13-24-20-15(21(31)26-10-5-4-8-18(26)25-20)12-17-22(32)27(23(33)34-17)11-9-19(29)30/h1-8,10,12,16,24,28H,9,11,13H2,(H,29,30)/t16-/m0/s1 |
| InChIK | PLIIZIOABSEIHJ-INIZCTEOSA-N |
| TotalMolweight | 496.567 |
| Molweight | 496.567 |
| MonoisotopicMass | 496.087511 |
| CLogP | -0.4317 |
| CLogS | -4.384 |
| H Acceptors | 9 |
| H Donors | 3 |
| TotalSurfaceArea | 358.35 |
| Relative PSA | 0.39314 |
| PolarSurfaceArea | 179.93 |
| Druglikeness | 6.8637 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.5 |
| Fragments | 1 |
| Non HAtoms | 34 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| StereoCenters | 1 |
| Rotatable Bond | 8 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 1 |
| Aromatic Atoms | 6 |
| Sp3Atoms | 8 |
| Symmetricatoms | 2 |
| Amides | 2 |
| BasicNitrogens | 1 |
| AcidicOxygens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - 3-[(5Z)-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid | 2 - 3-[(5Z)-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid